Sirijit Suttajit

1.3k total citations
42 papers, 682 citations indexed

About

Sirijit Suttajit is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Sirijit Suttajit has authored 42 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 11 papers in Cognitive Neuroscience. Recurrent topics in Sirijit Suttajit's work include Schizophrenia research and treatment (13 papers), Treatment of Major Depression (12 papers) and Attention Deficit Hyperactivity Disorder (11 papers). Sirijit Suttajit is often cited by papers focused on Schizophrenia research and treatment (13 papers), Treatment of Major Depression (12 papers) and Attention Deficit Hyperactivity Disorder (11 papers). Sirijit Suttajit collaborates with scholars based in Thailand, United Kingdom and Malaysia. Sirijit Suttajit's co-authors include Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Surinporn Likhitsathian, Kanchana Tangchonlatip, Siritree Suttajit, Michael Dewey, Sureeporn Punpuing, Jun Xia and Melanie Abas and has published in prestigious journals such as Scientific Reports, Cochrane Database of Systematic Reviews and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Sirijit Suttajit

40 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sirijit Suttajit Thailand 16 371 155 138 121 102 42 682
Christophe Arbus France 16 376 1.0× 207 1.3× 130 0.9× 93 0.8× 149 1.5× 55 903
Jan Jaracz Poland 13 232 0.6× 94 0.6× 101 0.7× 136 1.1× 85 0.8× 34 550
Melina Siamouli Greece 17 360 1.0× 214 1.4× 94 0.7× 94 0.8× 59 0.6× 38 768
Franck Baylé France 14 325 0.9× 198 1.3× 94 0.7× 124 1.0× 115 1.1× 28 664
S. O. W. Jensen Denmark 14 363 1.0× 176 1.1× 137 1.0× 137 1.1× 151 1.5× 15 850
Duk‐In Jon South Korea 17 536 1.4× 258 1.7× 220 1.6× 103 0.9× 95 0.9× 100 889
Leszek Bidzan Poland 14 224 0.6× 169 1.1× 98 0.7× 88 0.7× 56 0.5× 67 635
Jerónimo Sáiz Ruiz Spain 12 285 0.8× 134 0.9× 95 0.7× 89 0.7× 58 0.6× 37 569
Azorin Jm France 15 425 1.1× 142 0.9× 143 1.0× 74 0.6× 58 0.6× 64 608
Sang‐Woo Hahn South Korea 15 172 0.5× 148 1.0× 93 0.7× 85 0.7× 112 1.1× 45 589

Countries citing papers authored by Sirijit Suttajit

Since Specialization
Citations

This map shows the geographic impact of Sirijit Suttajit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sirijit Suttajit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sirijit Suttajit more than expected).

Fields of papers citing papers by Sirijit Suttajit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sirijit Suttajit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sirijit Suttajit. The network helps show where Sirijit Suttajit may publish in the future.

Co-authorship network of co-authors of Sirijit Suttajit

This figure shows the co-authorship network connecting the top 25 collaborators of Sirijit Suttajit. A scholar is included among the top collaborators of Sirijit Suttajit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sirijit Suttajit. Sirijit Suttajit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Srisurapanont, Manit, et al.. (2024). Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis. General Hospital Psychiatry. 87. 124–133. 10 indexed citations
3.
Srisurapanont, Manit, et al.. (2022). Antidepressants for depressed patients with type 2 diabetes mellitus: A systematic review and network meta-analysis of short-term randomized controlled trials. Neuroscience & Biobehavioral Reviews. 139. 104731–104731. 17 indexed citations
4.
Srisurapanont, Manit, et al.. (2020). Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis. Drug and Alcohol Dependence. 219. 108467–108467. 11 indexed citations
5.
Suttajit, Sirijit, et al.. (2019). Parvalbumin Promoter Methylation Altered in Major Depressive Disorder. International Journal of Medical Sciences. 16(9). 1207–1214. 9 indexed citations
6.
Maneeton, Narong, et al.. (2019). Aripiprazole in acute treatment of children and adolescents with autism spectrum disorders: A systematic review and meta-analysis. European Neuropsychopharmacology. 29. S142–S143. 1 indexed citations
7.
Maneeton, Narong, et al.. (2018). Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment. Volume 14. 3063–3072. 20 indexed citations
8.
Srisurapanont, Manit, et al.. (2017). Discrepancy between objective and subjective cognition in adults with major depressive disorder. Scientific Reports. 7(1). 3901–3901. 92 indexed citations
9.
Maneeton, Narong, et al.. (2015). Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials. Drug Design Development and Therapy. 9. 1927–1927. 16 indexed citations
10.
Suttajit, Sirijit, et al.. (2015). Predictors of quality of life among individuals with schizophrenia. Neuropsychiatric Disease and Treatment. 11. 1371–1371. 29 indexed citations
11.
Suttajit, Sirijit, et al.. (2013). Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia. Neuropsychiatric Disease and Treatment. 9. 941–941. 28 indexed citations
12.
Srisurapanont, Manit, et al.. (2013). Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry. Neuropsychiatric Disease and Treatment. 9. 1751–1751. 10 indexed citations
13.
Suttajit, Sirijit, et al.. (2013). Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia. Neuropsychiatric Disease and Treatment. 9. 113–113. 7 indexed citations
14.
Suttajit, Sirijit, et al.. (2012). An open-label study of adjunctive repetitive transcranial magnetic stimulation (rTMS) for partial remission in major depressive disorder. International Journal of Psychiatry in Clinical Practice. 16(2). 98–102. 7 indexed citations
16.
Suttajit, Sirijit, et al.. (2011). Prevalence of and Factors Associated with Depression in Patients with Schizophrenia in a University Hospital: A Post-hoc Analysis. 50(4). 115–121. 2 indexed citations
17.
Srisurapanont, Manit, et al.. (2011). Patterns of alcohol dependence in Thai drinkers: A differential item functioning analysis of gender and age bias. Addictive Behaviors. 37(2). 173–178. 13 indexed citations
18.
Suttajit, Sirijit, Sureeporn Punpuing, Tawanchai Jirapramukpitak, et al.. (2010). Impairment, disability, social support and depression among older parents in rural Thailand. Psychological Medicine. 40(10). 1711–1721. 45 indexed citations
19.
Suttajit, Sirijit, et al.. (2010). COMPARISON OF METHODS USED IN MEASURING NONADHERENCE AND THE BARRIERS AGAINST ADHERENCE TO ANTIPSYCHOTIC DRUGS IN OUTPATIENTS WITH SCHIZOPHRENIA. 49(3). 97–103. 2 indexed citations
20.
Suttajit, Sirijit. (2009). THE ROLES OF NEUROTRANSMITTERS, HORMONES AND BRAIN-DERIVED NEUROTROPHIC FACTORS IN THE PATHOGENESIS OF DEPRESSION. 48(1). 35–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026